• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Sampling restrictions modestly alter prescribing behavior

Article

Implementation of a policy restricting drug sampling and pharmaceutical industry detailing in a small rural clinic resulted in modest reductions in the prescription of branded and promoted drugs, according to research published in the September/October issue of the "Annals of Family Medicine."

Implementation of a policy restricting drug sampling and pharmaceutical industry detailing in a small rural clinic resulted in modest reductions in the prescription of branded and promoted drugs, according to research published in the September/October issue of the Annals of Family Medicine, HealthDay News reported.

Daniel M. Hartung, PharmD, MPH, of the Oregon State University College of Pharmacy and colleagues evaluated prescribing trends in a rural Oregon family practice clinic to assess the effect on prescribing behavior of a policy restricting pharmaceutical industry detailing and sampling.

The researchers found that the use of promoted brands decreased by 1.43%, while use of non-promoted brands increased by 3.04%. Prescriptions for branded drugs for respiratory disease fell 11.34% compared with those written by a control group of prescribers, and there was a 9.98% and 11.34% decrease in prescriptions of promoted brands for cholesterol-lowering drugs and antidepressants, respectively. The trend in average per-prescription cost for lipid-lowering drugs was reduced by 70 cents per prescription monthly.

Immediately after policy implementation, the average prescription drug costs overall increased by $5.18.

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Dr. Charles Lee
© 2023 MJH Life Sciences

All rights reserved.